Speaker Companion: SSRI Cross-Titration Guide

Safe Switching Strategies for Telepsychiatry Settings

⏱ Total Duration: 45 minutes
πŸ‘₯ Audience: PMHNPs, Residents
πŸ“Š 20 Slides
🎯 Level: Intermediate
1

Title Slide

2 min
Speaker Notes
  • Welcome participants; acknowledge this is a high-frequency clinical scenario
  • Emphasize telepsychiatry-specific challenges (no direct observation, limited crisis monitoring)
  • Set expectation: practical, actionable guidance they can use Monday morning
  • Mention that questions are welcome throughout β€” this is interactive
πŸ’‘ Delivery Tip

Make eye contact with different sections of the room. Pause after "telepsychiatry" to let the challenge sink in.

Anticipated Questions
Is this applicable to in-person practice too?
Easy β–Ό

Absolutely. The principles apply universally, but telepsychiatry requires extra caution due to limited monitoring. In-person practice gives you more flexibility for direct switch strategies.

Will we cover SNRIs too?
Easy β–Ό

Principles are similar, but we'll focus on SSRIs today. Venlafaxine has notably worse discontinuation than SSRIs β€” treat it like paroxetine (slow taper). Duloxetine is intermediate.

2

Learning Objectives

1 min
Speaker Notes
  • Read through objectives quickly β€” don't linger
  • Highlight "written cross-taper schedules" as the practical takeaway
  • Note that differential diagnosis is often where clinicians get confused
🎯 Key Point

By the end, they should feel confident writing a day-by-day cross-taper schedule for any SSRI switch.

Anticipated Questions
Will we get sample schedules?
Easy β–Ό

Yes β€” the enrichment materials include a customizable taper calculator. The presentation shows the standard 4-week template.

3

Section 1: Why This Matters

Section Transition

This section establishes the stakes. We want participants to understand that SSRI switching isn't just routine β€” it carries real risks if done poorly, especially in telehealth.

πŸ’‘ Transition Phrase

"Before we get to the how, let's talk about why getting this right matters..."

4

SSRI Switching is Common

4 min
Speaker Notes
  • Start with the 30-50% inadequate response stat β€” this resonates
  • Acknowledge that insurance/formulary changes are frustrating realities
  • For telepsychiatry challenges, pause after each bullet β€” let them nod
  • "No sample medications" often gets a knowing laugh
πŸ’‘ Engagement Technique

Ask: "How many of you have had a patient run out of medication during a switch?" (hands go up) "That's exactly why we need structured plans."

Anticipated Questions
What about pregnancy β€” which SSRIs are safest?
Medium β–Ό

Sertraline and fluoxetine have the best pregnancy data. Paroxetine has been associated with cardiac defects in first trimester exposure. Escitalopram and citalopram are generally considered reasonable alternatives. Always coordinate with OB.

How do you handle the "I can't afford this anymore" switch?
Medium β–Ό

This is where cross-taper is essential β€” you can't afford a gap in coverage. Check if the new medication is actually on their formulary before switching. Sometimes a prior auth is worth fighting for if the patient is stable.

5

Five Core Principles

5 min
Speaker Notes
  • Principle 1: Emphasize the norfluoxetine metabolite β€” this is often missed
  • Principle 2: "Cross-taper is default" β€” this is the main message
  • Principle 3: Patient education prevents panic calls
  • Principle 4: Serotonin syndrome fear is overblown for SSRIβ†’SSRI
  • Principle 5: Written plans are non-negotiable in telehealth
🎯 Anchor Point

If they remember nothing else: "Cross-taper is the default for telepsychiatry."

Anticipated Questions
Is serotonin syndrome really that rare with SSRI overlap?
Hard β–Ό

True serotonin syndrome from SSRI-to-SSRI switching is exceedingly rare at therapeutic doses. The risk is conflated with activation side effects (anxiety, restlessness). True serotonin syndrome involves clonus, hyperthermia, autonomic instability. If you're seeing that, it's an emergency regardless of cause.

What if the patient refuses to be on two medications?
Medium β–Ό

Explain that the overlap is brief (usually 1-2 weeks) and prevents a much worse experience of discontinuation. Frame it as "bridging" rather than "being on two antidepressants." If they still refuse, document and consider direct switch with close monitoring.

6

Section 2: SSRI Profiles

Section Transition

Now we get into the pharmacology. This section is reference-heavy β€” participants will want to photograph or screenshot the tables. Encourage this.

πŸ’‘ Transition Phrase

"Let's look at the tools in our toolbox β€” the SSRIs themselves."

7

SSRI Dose Equivalency Table

4 min
Speaker Notes
  • Point out fluoxetine row β€” highlight the norfluoxetine metabolite
  • Note citalopram max dose reduction for elderly (QTc risk)
  • Paroxetine: emphasize "no active metabolites" = faster washout = worse discontinuation
  • Fluvoxamine: mention it's rarely used for depression (OCD mainly)
πŸ’‘ Teaching Point

"These equivalencies are approximate β€” don't get too hung up on exact milligrams. The half-life matters more than the dose."

Anticipated Questions
Why is escitalopram "more potent" at 10 mg?
Medium β–Ό

Escitalopram is the S-enantiomer of citalopram and has higher binding affinity to the serotonin transporter. It's roughly twice as potent, which is why 10 mg escitalopram β‰ˆ 20 mg citalopram. This also means side effects can be more pronounced at equivalent doses.

Is the 40 mg citalopram limit for >60yo still relevant?
Hard β–Ό

Yes β€” FDA black box warning for QTc prolongation at doses >40 mg, and >60 years is a risk factor. The 20 mg limit for elderly is conservative but appropriate given cardiac risks. Escitalopram has less QTc effect and may be preferred in cardiac patients.

8

Half-Life Comparison

3 min
Speaker Notes
  • Walk through the bars left to right β€” build the contrast
  • Pause at fluoxetine β€” "4-6 DAYS, not hours"
  • Explain the clinical pearl: blessing and curse
  • Connect to next section: this is why switching FROM fluoxetine is different
🎯 Memory Anchor

"Fluoxetine is the only SSRI where you can stop cold turkey without discontinuation."

Anticipated Questions
How long does CYP2D6 inhibition last after stopping fluoxetine?
Hard β–Ό

CYP2D6 inhibition can persist for 3-5 weeks after stopping fluoxetine due to norfluoxetine. This matters if you're starting a drug metabolized by CYP2D6 (tramadol, codeine, many antipsychotics). The new SSRI may also be affected.

9

Section 3: Switching Strategies

Section Transition

This is the core of the presentation β€” the "how." Participants have been waiting for this. Build some anticipation.

πŸ’‘ Transition Phrase

"Now let's get to what you came for β€” exactly HOW to switch."

10

Strategy 1: Direct Switch (Same Day)

3 min
Speaker Notes
  • Emphasize this is NOT the default for telehealth
  • Only for reliable patients with good med management history
  • Best for short half-life to short half-life (sertraline ↔ escitalopram)
  • The "telepsychiatry note" box is critical β€” read it aloud
πŸ’‘ Cautionary Note

"I've seen direct switches go wrong when the patient misunderstood and took both at full dose for a week. Written instructions prevent this."

Anticipated Questions
Can I direct switch from fluoxetine?
Medium β–Ό

Yes β€” but it's different. You stop fluoxetine and wait 1-2 weeks before starting the new SSRI. The long half-life means fluoxetine is still "tapering itself" during that gap. Don't start the new SSRI immediately.

11

Strategy 2: Cross-Taper (Recommended)

6 min
Speaker Notes
  • This is the MONEY SLIDE β€” spend time here
  • Walk through the table week by week
  • Emphasize the overlap is brief and safe
  • Click the reveal button for SSRI-specific adjustments
  • Paroxetine gets special attention β€” slowest taper
🎯 Critical Detail

The 4-week schedule is a template β€” paroxetine needs 6-8 weeks. Fluoxetine can be faster.

Anticipated Questions
What if the patient gets side effects during the overlap?
Medium β–Ό

Usually this is activation from the new SSRI, not serotonin syndrome. Slow the titration of the new SSRI, or pause at current dose. Rarely need to stop both. Most "side effects" are actually discontinuation from the old SSRI.

Can I cross-taper to fluoxetine?
Hard β–Ό

Yes, but start fluoxetine LOW (10 mg) because it accumulates. By week 4 when you're at "target dose," fluoxetine may still be building. Consider 20 mg the true starting dose and titrate to 40 mg if needed after 4+ weeks.

12

Strategy 3: Washout (Stop-and-Wait)

2 min
Speaker Notes
  • Emphasize: NOT for SSRIβ†’SSRI
  • The warning box is important β€” read it
  • Only for MAOIs β€” this is where serotonin syndrome risk is real
  • 5 weeks from fluoxetine due to norfluoxetine
πŸ’‘ Teaching Point

"If you're switching between SSRIs, you should almost never need a washout. If someone tells you to do a 2-week washout between sertraline and escitalopram, they're wrong."

Anticipated Questions
What about switching to or from trazodone?
Medium β–Ό

Trazodone is an SARI, not an SSRI, but has serotonergic activity. Cross-taper is still appropriate. The only class that truly requires washout is MAOIs (phenelzine, tranylcypromine, selegiline at antidepressant doses).

13

Which Strategy? Decision Tree

4 min
Speaker Notes
  • This is interactive β€” walk through the tree
  • Start with MAOI question (most important safety check)
  • Click through nodes to show the logic
  • End with "standard cross-taper" as the most common outcome
πŸ’‘ Engagement

Ask audience: "Where do you think most patients end up on this tree?" (Answer: standard cross-taper)

Anticipated Questions
What about switching to vortioxetine or vilazodone?
Hard β–Ό

These multimodal antidepressants can be treated like SSRIs for switching purposes. Cross-taper is appropriate. Vortioxetine has a 66-hour half-life (intermediate). Vilazodone is ~25 hours. Neither requires special washout considerations.

14

Section 4: Telepsychiatry Monitoring

Section Transition

Now we shift from "what to do" to "how to monitor." This is where telepsychiatry gets real β€” you can't see the patient, so your systems matter more.

πŸ’‘ Transition Phrase

"The switch is only half the battle β€” monitoring is where telepsychiatry lives or dies."

15

Telehealth Monitoring Checklist

4 min
Speaker Notes
  • Pre-switch: verify pill supply β€” patients often don't have both meds
  • Written schedule: send via portal AND review verbally
  • Week 1 check-in: brief, focused on discontinuation symptoms
  • Week 4: full visit with response assessment
🎯 Documentation Tip

Document that you provided a written schedule and reviewed emergency symptoms. This protects you medicolegally if something goes wrong.

Anticipated Questions
Do I need to do video visits for all check-ins?
Easy β–Ό

No β€” phone is fine for weeks 1 and 2 check-ins. Video is preferred for week 4 to assess clinical response. Portal messaging can supplement but shouldn't replace live contact during a switch.

What if I can't reach the patient for the check-in?
Medium β–Ό

Document attempts. Send portal message with specific questions ("Are you having dizziness? Brain zaps?"). If no response by day 3-4, consider emergency contact or pharmacy check. This is why reliable patients are selected for direct switch.

16

Discontinuation vs Serotonin Syndrome vs Relapse

5 min
Speaker Notes
  • This is where clinicians get confused β€” spend time here
  • Walk through the table row by row
  • Emphasize timing: discontinuation is immediate, relapse is delayed
  • Click reveal for the "brain zaps" teaching point
πŸ’‘ Clinical Pearl

"If a patient calls 3 days after stopping paroxetine with dizziness and 'electric shocks,' that's discontinuation, not an emergency. Reassure them."

Anticipated Questions
How do I actually diagnose serotonin syndrome?
Hard β–Ό

Use the Hunter Criteria: clonus is the hallmark. Look for spontaneous, inducible, or ocular clonus PLUS agitation, sweating, tremor, hyperreflexia, hyperthermia. If no clonus, it's probably not serotonin syndrome. Sternbach criteria are less specific.

What if symptoms start 1 week after stopping?
Medium β–Ό

With fluoxetine, discontinuation can be delayed 1-2 weeks due to long half-life. With other SSRIs, 1 week is the gray zone β€” could be persistent discontinuation or early relapse. If new SSRI was started, could be side effects. Context matters.

17

Practical Pearls

3 min
Speaker Notes
  • Rapid-fire through these β€” they're memory aids
  • "Brain zaps" β€” emphasize this is real to patients
  • First-week anxiety β€” reassurance prevents early discontinuation
  • Fluoxetine bridge β€” advanced technique for severe cases
🎯 Take-Home

Liquid formulations are underutilized. Many SSRIs come in liquid (fluoxetine, sertraline, paroxetine) for precise tapering.

Anticipated Questions
How do I do a fluoxetine bridge?
Hard β–Ό

For severe discontinuation from paroxetine/venlafaxine: Stop offending drug, start fluoxetine 10-20 mg for 1-2 weeks, then stop fluoxetine (it self-tapers). Some evidence this reduces discontinuation severity. Then start new SSRI after fluoxetine washout if needed.

18

Bottom Line

3 min
Speaker Notes
  • This is the summary β€” drive home the main message
  • Read the bottom line quote slowly
  • Walk through the 5 key steps
  • End with the warning about paroxetine
🎯 Final Anchor

"Cross-taper is the default. Washout is for MAOIs only. When in doubt, go slower."

Anticipated Questions
Can you give us a one-line summary for our notes?
Easy β–Ό

"For telepsychiatry SSRI switches: cross-taper over 4 weeks (6-8 for paroxetine), provide written schedules, check in at weeks 1, 2, and 4."

19

References

1 min
Speaker Notes
  • Brief mention of key sources
  • Stahl is the bible
  • UpToDate for practical guidance
  • Direct to enrichment materials for full reference list
Anticipated Questions

Typically no questions on reference slide. Keep moving to allow time for closing discussion.

20

Thank You / Discussion

5 min
Speaker Notes
  • Thank participants for attention
  • Open for questions β€” this is where real learning happens
  • Have enrichment materials ready to share
  • Offer to review specific cases (de-identified)
πŸ’‘ Closing Tip

End with: "The patients you'll help with this knowledge are worth the extra documentation time."

Anticipated Questions
Where can I get the taper calculator?
Easy β–Ό

The enrichment materials include an interactive HTML taper calculator. It's also available in the shared drive under Clinical Tools. You can customize it for your practice's formulary.

Can we get CME for this?
Easy β–Ό

Check with your institution's CME coordinator. This content aligns with APA and AANP pharmacology requirements. The enrichment materials include learning objectives and assessment questions if needed for credit.